NCLifeSci Medical Device Luncheon and Forum: Diagnostic Testing - Will FDA’s Final Rule be the Final Word
Date and Time
Tuesday May 21, 2024
11:30 AM - 2:00 PM EDT
11:30 a.m. Registration/Check in
11:40 a.m. Networking Lunch
12:10 p.m. Program
1:25 p.m. Closing
1:30 p.m. Networking
Location
NC Biotech Center
15 TW Alexander Dr.
RTP, NC 27709
Fees/Admission
Registration is available to NCLifeSci members and their representatives at no cost. If you are interested in membership, please contact Membership Director Natacha Janvier.
Contact Information
Amber Niebauer, Events Director, NCLifeSci
Send Email
Description
Join NCLifeSci members for a networking lunch and a panel discussion focused on diagnostic testing. Hear from key leaders on the importance of getting the diagnostics market right, as it’s a critical part in the continuum of care. Therapeutic and device companies are finding and creating cures and solutions that should be based on accurate diagnoses.
Panelists will
- cover the oversight and quality of laboratory-derived tests and in vitro diagnostics,
- discuss current regulation and modernization of regulation,
- discuss pros and cons of FDA rule making versus legislation and FDA oversight, and
- explore how to advance patient care and public health.
- Anna Abram, senior advisor, Akin Gump Strauss Hauer & Feld LLP
- Nicole Bell, chief business officer, Galaxy Diagnostics
- Matthew Roberts, health care practice group leader and regulatory section head, Maynard Nexsen (moderator)
- Hannah Yan, senior research scientist, regulatory strategy and product development, RTI International
Thank you to the Economic Development Partnership of North Carolina and Maynard Nexsen for sponsoring this forum.
If you are interested in sponsoring the Medical Device Forum, contact Membership Director Natacha Janvier for more details.
